The Structural Genomics Consortium Announces that Janssen has joined its Public-Private Drug Discovery Partnership
The Structural Genomics Consortium (SGC) announced today that Janssen Pharmaceuticals NV has joined its group to partner in the investigation of epigenetics-based drug research, a new and burgeoning field in the development of future medicines. One of the largest ever early-stage research partnerships between the pharmaceutical industry and the public sector, the SGC receives its […]